[Federal Register Volume 70, Number 148 (Wednesday, August 3, 2005)]
[Notices]
[Page 44662]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-15373]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


National Mammography Quality Assurance Advisory Committee; Notice 
of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: National Mammography Quality Assurance Advisory 
Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on September 26 and 27, 
2005, from 9 a.m. to 6 p.m.
    Location: Holiday Inn, Walker/Whetstone Rooms, Two Montgomery 
Village Ave., Gaithersburg, MD.
    Contact Person: Charles Finder, Center for Devices and Radiological 
Health (HFZ-240), Food and Drug Administration, 1350 Piccard Dr., 
Rockville, MD 20850, 301-594-3332, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 3014512397. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: The committee will discuss the following issues:
    (1) Regulatory and nonregulatory mechanisms to enhance mammography 
quality while reducing the regulatory and inspection burden on 
facilities;
    (2) Recommendations made by the Institute of Medicine regarding the 
current Mammography Quality Standards Act (MQSA) program, 
interventional mammography, and nonmammographic breast imaging 
procedures; and
    (3) All relevant guidance documents issued since the last meeting.
    The committee will also receive updates on recently approved 
alternative standards, voluntary stereotactic accreditation programs, 
and the radiological health program. MQSA regulations and guidance 
documents are available to the public on the Internet at http://www.fda.gov/cdrh/mammography.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by September 5, 
2005. Oral presentations from the public will be scheduled between 
approximately 9:30 a.m. and 10:30 a.m. on both days. Time allotted for 
each presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before September 5, 
2005, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Shirley Meeks at 
240-276-0450, ext. 105, at least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: July 27, 2005.
Sheila Dearybury Walcoff,
Associate Commissioner for External Relations.
[FR Doc. 05-15373 Filed 8-2-05; 8:45 am]
BILLING CODE 4160-01-S